Table 1.
Baseline characteristics of patients in the aspirin and non-aspirin groups.
| Characteristic | Non-aspirin (n = 71) | Aspirin (n = 133) |
|---|---|---|
| Age, years, mean (SD) | 48 (34, 50) | 47 (37.5, 54) |
| Gender, n (%) | ||
| Male | 40 (56.3) | 68 (51.1) |
| Female | 31 (43.7) | 65 (48.9) |
| Symptoms, n (%) | ||
| TIA | 41 (57.8) | 68 (51.1) |
| Cerebral infarction | 16 (22.5) | 35 (26.3) |
| Others | 14 (19.7) | 30 (22.6) |
| Diabetes, n (%) | 7 (9.9) | 15 (11.3) |
| Hypertension, n (%) | 21 (29.6) | 47 (35.3) |
| Hyperlipidemia, n (%) | 17 (0.24) | 29 (21.8) |
| Smoking history, n (%) | 22 (31.0) | 32 (24.1) |
| Drinking history, n (%) | 13 (18.3) | 25 (18.9) |
| Family history of cerebrovascular disease, n (%) | 14 (19.7) | 26 (19.6) |
| mRS at admission, n (%) | ||
| 0–1 | 39 (54.9) | 87 (65.4) |
| 2–3 | 29 (40.8) | 39 (29.3) |
| 4–5 | 3 (4.2) | 7 (5.3) |
| Suzuki stage, n (%) | ||
| 1 | – | – |
| 2 | 9 (12.7) | 21 (15.8) |
| 3 | 36 (50.7) | 61 (45.9) |
| 4 | 20 (28.2) | 43 (32.3) |
| 5 | 6 (8.5) | 8 (6.0) |
| 6 | – | – |
| Staging of cerebral perfusion at admission, n (%) | ||
| 1 | 7 (9.9) | 11 (8.3) |
| 2 | 19 (26.8) | 42 (31.6) |
| 3 | 23 (32.4) | 45 (33.8) |
| 4 | 22 (30.9) | 35 (26.3) |
| Operation side, n (%) | ||
| Left | 41 (57.7) | 84 (63.2) |
| Right | 30 (42.3) | 49 (36.8) |
SD, standard deviation; TIA, transient ischemic attack; mRS, modified Rankin scale.